AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34221941 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position spinal anesthesia
Number of subjects: 106
Study 34221941 — intervention group
Group type: COMPARATOR
Intervention: Lateral position spinal anesthesia
Number of subjects: 106
Study 33434519 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified tooth sectioning method
Number of subjects: 300
Study 33434519 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 300
Study 32180155 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection into the pectoralis major and teres major muscles
Number of subjects: 60
Study 32180155 — intervention group
Group type: COMPARATOR
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 60
Study 32180155 — intervention group
Group type: COMPARATOR
Intervention: Comparison between BoNT‐A and SSNB
Number of subjects: 60
Study 33545163 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag
Number of subjects: 1156
Study 33545163 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1156
Study 35512064 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care combined with vasopressin
Number of subjects: 0
Study 35512064 — intervention group
Group type: COMPARATOR
Intervention: Conventional care combined with vasopressin
Number of subjects: 0
Study 34139859 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein B (ApoB) lowering
Number of subjects: 0
Study 34139859 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein(a)
Number of subjects: 0
Study 34139859 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-small very-low-density lipoprotein particle concentration
Number of subjects: 0
Study 34139859 — intervention group
Group type: EXPERIMENTAL
Intervention: Large low-density lipoprotein particle concentration
Number of subjects: 0
Study 35533737 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) + Aerobic Exercise
Number of subjects: 40
Study 35533737 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Exercise
Number of subjects: 40
Study 33401219 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATORVA) 40 mg daily for 6 months
Number of subjects: 160
Study 33401219 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin (ROSUVA) 10 mg daily for 6 months
Number of subjects: 160
Study 32134758 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary Adenosine (two bolus doses)
Number of subjects: 104
Study 32134758 — intervention group
Group type: COMPARATOR
Intervention: IC normal saline (placebo group)
Number of subjects: 104
Study 34368971 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-step irradiance schedule
Number of subjects: 90
Study 34368971 — intervention group
Group type: COMPARATOR
Intervention: Two-step irradiance schedule
Number of subjects: 90
Study 34368971 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 90
Study 34656378 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13-MDV
Number of subjects: 0
Study 34656378 — intervention group
Group type: COMPARATOR
Intervention: PCV13-PFS
Number of subjects: 0
Study 36960162 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b and lopinavir-ritonavir
Number of subjects: 62
Study 36960162 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 62
Study 33647972 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton radiotherapy (PT)
Number of subjects: 90
Study 33647972 — intervention group
Group type: COMPARATOR
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 90
Study 32907617 — intervention group
Group type: COMPARATOR
Intervention: Sarilumab 150 mg vs. placebo
Number of subjects: 2112
Study 32907617 — intervention group
Group type: COMPARATOR
Intervention: Sarilumab 200 mg vs. placebo
Number of subjects: 2112
Study 32907617 — intervention group
Group type: COMPARATOR
Intervention: Sarilumab 200 mg vs. adalimumab 40 mg
Number of subjects: 2112
Study 37145935 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscope with a non‐channelled Macintosh blade
Number of subjects: 330
Study 37145935 — intervention group
Group type: COMPARATOR
Intervention: Flexible fibrescope
Number of subjects: 330
Study 33982623 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab
Number of subjects: 648
Study 33982623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 648
Study 35435159 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined application of palpebral margin cleaning with cotton pads and levofloxacin eye drops for three days before surgery
Number of subjects: 61
Study 35435159 — intervention group
Group type: COMPARATOR
Intervention: Levofloxacin eye drops alone for three consecutive days
Number of subjects: 61
Study 34030910 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical screen group (N = 40)
Number of subjects: 120
Study 34030910 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer group (N = 40)
Number of subjects: 120
Study 34030910 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 40)
Number of subjects: 120
Study 32872348 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced Plate Intervention
Number of subjects: 0
Study 35139918 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet intervention (DIET) - 1 hour per week of group-based dietary counseling including education, goal setting, and strategy training.
Number of subjects: 14
Study 35139918 — intervention group
Group type: COMPARATOR
Intervention: Control education (ED) - 1 hour per week of group-based brain health education classes.
Number of subjects: 14
Study 33410885 — intervention group
Group type: EXPERIMENTAL
Intervention: Osimertinib plus Bevacizumab
Number of subjects: 87
Study 33410885 — intervention group
Group type: COMPARATOR
Intervention: Osimertinib alone
Number of subjects: 87
Study 33976369 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic web-based decision aid
Number of subjects: 0
Study 33976369 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32295779 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 480
Study 32295779 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy as treatment as usual
Number of subjects: 480
Study 35717531 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training
Number of subjects: 18
Study 35717531 — intervention group
Group type: COMPARATOR
Intervention: No-video training
Number of subjects: 18
Study 32305573 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture trigeminal nerve stimulation plus body acupuncture (EA/TNS + BA)
Number of subjects: 93
Study 32305573 — intervention group
Group type: COMPARATOR
Intervention: Minimum acupuncture stimulation (MAS)
Number of subjects: 93
Study 33158702 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI examination with acoustic noise reduction
Number of subjects: 174
Study 33158702 — intervention group
Group type: COMPARATOR
Intervention: Standard MRI examination
Number of subjects: 174
Study 34569538 — intervention group
Group type: EXPERIMENTAL
Intervention: CMV‐HyperIg treatment upon seroconversion
Number of subjects: 9535
Study 34569538 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care with CMV‐serostatus testing at end of pregnancy (control)
Number of subjects: 9535
Study 36415489 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate and Coenzyme Q10
Number of subjects: 149
Study 36415489 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate only
Number of subjects: 149
Study 36415489 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate and Coenzyme Q10 (non-obese women)
Number of subjects: 149
Study 36415489 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate only (obese women)
Number of subjects: 149
Study 32272389 — intervention group
Group type: EXPERIMENTAL
Intervention: Roommates who desisted from using marijuana (used before college but stopped in college)
Number of subjects: 1953
Study 32272389 — intervention group
Group type: COMPARATOR
Intervention: Roommates who never used marijuana, always used, or started using after entering college
Number of subjects: 1953
Study 32272389 — intervention group
Group type: COMPARATOR
Intervention: Respondents who did not use marijuana before college
Number of subjects: 1953
Study 36263875 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic education plus promotora home visits (n = 22)
Number of subjects: 48
Study 36263875 — intervention group
Group type: COMPARATOR
Intervention: Clinic education (n = 26)
Number of subjects: 48
Study 36263875 — intervention group
Group type: EXPERIMENTAL
Intervention: Promotora group
Number of subjects: 48
Study 36263875 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study 33386901 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking-based intervention (28 sessions over 8 weeks, 2-5 times/week, with 1 supervised session per week by a physiotherapist)
Number of subjects: 20
Study 33386901 — intervention group
Group type: COMPARATOR
Intervention: Control group (verbal and written advice on the benefits of exercise)
Number of subjects: 20
Study 32931691 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralization
Number of subjects: 14
Study 32931691 — intervention group
Group type: EXPERIMENTAL
Intervention: Radialization
Number of subjects: 14
Study 36217901 — intervention group
Group type: EXPERIMENTAL
Intervention: RP7214 single-dose (100, 200, and 400 mg QD)
Number of subjects: 42
Study 36217901 — intervention group
Group type: EXPERIMENTAL
Intervention: RP7214 multiple doses (200 and 400 mg BID for 7 days)
Number of subjects: 42
Study 36217901 — intervention group
Group type: EXPERIMENTAL
Intervention: RP7214 food effect (single dose of 200 mg)
Number of subjects: 42
Study 36217901 — intervention group
Group type: EXPERIMENTAL
Intervention: RP7214 (general)
Number of subjects: 42
Study 34193630 — intervention group
Group type: EXPERIMENTAL
Intervention: WhatsApp-based physical activity intervention for children with ASD for 4 weeks
Number of subjects: 14
Study 35536579 — intervention group
Group type: EXPERIMENTAL
Intervention: Community and clinic education intervention program (Ask About Aspirin campaign)
Number of subjects: 8342
Study 32058185 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface electrical stimulation (SES) training for 8 weeks
Number of subjects: 34
Study 32058185 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SES training)
Number of subjects: 34
Study 34133067 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction plus cryotherapy
Number of subjects: 50
Study 34133067 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy alone
Number of subjects: 50
Study 36086876 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-eluting stents containing mometasone furoate
Number of subjects: 95
Study 36086876 — intervention group
Group type: COMPARATOR
Intervention: Control side (no steroid-eluting stents)
Number of subjects: 95
Study 32622913 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1875
Study 32622913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-procedural left ventricular ejection fraction (LVEF)<45%
Number of subjects: 1875
Study 32622913 — intervention group
Group type: EXPERIMENTAL
Intervention: eGFR≤30 mL/min/1.73m2 or renal replacement therapy
Number of subjects: 1875
Study 32951725 — intervention group
Group type: EXPERIMENTAL
Intervention: Laying on of hands with Spiritual connection (LHS)
Number of subjects: 84
Study 32951725 — intervention group
Group type: COMPARATOR
Intervention: Control - Laying on of hands without Spiritual connection (control-LHW)
Number of subjects: 84
Study 35457469 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed training
Number of subjects: 20
Study 35457469 — intervention group
Group type: COMPARATOR
Intervention: Accuracy training
Number of subjects: 20
Study 32711121 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire sent with a pen
Number of subjects: 4812
Study 32711121 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire resent
Number of subjects: 4812
Study 32711121 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survey participation
Number of subjects: 4812
Study 32711121 — intervention group
Group type: EXPERIMENTAL
Intervention: General agreement on quality of care improvement
Number of subjects: 4812
Study 32245961 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education programme for COPD in the context of multi-morbidity, delivered by general practice nurses in face-to-face sessions.
Number of subjects: 0
Study 35010730 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB supplementation
Number of subjects: 8
Study 35010730 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 8
Study 34293643 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer game assisted task specific exercises (CGATSE)
Number of subjects: 30
Study 34293643 — intervention group
Group type: COMPARATOR
Intervention: Occupational therapy (OT)
Number of subjects: 30
Study 35590347 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity (once daily) CTAR‐SwiFt exercise
Number of subjects: 60
Study 35590347 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity (twice daily) CTAR‐SwiFt exercises
Number of subjects: 60
Study 35590347 — intervention group
Group type: EXPERIMENTAL
Intervention: CTAR‐SwiFt intervention
Number of subjects: 60
Study 35590347 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 34271953 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of Astragalus Membranaceus Root (AMR)
Number of subjects: 18
Study 34271953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 32020485 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated exercise and health education program (self-directed home-based resistance training for 5 months)
Number of subjects: 0
Study 32020485 — intervention group
Group type: COMPARATOR
Intervention: Control group (health education program only)
Number of subjects: 0
Study 32020485 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated exercise and health education program
Number of subjects: 0
Study 32162497 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental transdermal gel (ETG)
Number of subjects: 48
Study 32162497 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel (PTG)
Number of subjects: 48
Study 32162497 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete multimodal treatment (ETG + external therapies, art therapies, neurofunctional reorganization)
Number of subjects: 48
Study 32162497 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly external therapies, art therapies, and neurofunctional reorganization with ETG
Number of subjects: 48
Study 615270428 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of unruptured AVMs grade 1 and 2
Number of subjects: 0
Study 615270428 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary team evaluation
Number of subjects: 0
Study 615270428 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment strategy defined by multidisciplinary team
Number of subjects: 0
Study 615270428 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective European Multidisciplinary Registry
Number of subjects: 0
Study 32020565 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged-release oxycodone/naloxone (OXN PR)
Number of subjects: 234
Study 32020565 — intervention group
Group type: COMPARATOR
Intervention: Prolonged-release oxycodone (OXY PR)
Number of subjects: 234
Study 33730384 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT plus treatment as usual (CBT4CBT+TAU)
Number of subjects: 63
Study 33730384 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT4CBT plus brief monitoring (CBT4CBT+monitoring)
Number of subjects: 63
Study 33730384 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 63
Study 32842839 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally-adapted treatment (CAT)
Number of subjects: 58
Study 32842839 — intervention group
Group type: COMPARATOR
Intervention: Standard evidence-based treatment (EBT)
Number of subjects: 58
Study 35934663 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training (PFMT) for 6 weeks (home exercise program)
Number of subjects: 43
Study 35934663 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment for OAB)
Number of subjects: 43
Study 32776430 — intervention group
Group type: EXPERIMENTAL
Intervention: One cup of espresso coffee per day
Number of subjects: 21
Study 32776430 — intervention group
Group type: EXPERIMENTAL
Intervention: Three cups of espresso coffee per day
Number of subjects: 21
Study 32776430 — intervention group
Group type: EXPERIMENTAL
Intervention: One cup of espresso coffee plus two CBPCC twice per day
Number of subjects: 21
Study 32776430 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 21
Study 32460699 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) 0.4 μg/kg over 10 mins followed by 0.4 μg/kg/h till the second day morning after surgery
Number of subjects: 160
Study 32460699 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline) administered similarly to DEX group
Number of subjects: 160
Study 32460699 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 160
Study 36027570 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 6263
Study 36027570 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study 32945145 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions (CBT and CBT + add on treatment)
Number of subjects: 61
Study 32945145 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 20 treatment sessions
Number of subjects: 61
Study 32945145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT)
Number of subjects: 61
Study 32945145 — intervention group
Group type: COMPARATOR
Intervention: General adolescent help-seeking population (HSP) receiving psychological interventions
Number of subjects: 61
Study 34907285 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash glucose monitoring (FGM)
Number of subjects: 146
Study 34907285 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring blood glucose (SMBG)
Number of subjects: 146
Study 32343765 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-diversified diet (NDD) group, n=15, received a 12-week structured dietary intervention.
Number of subjects: 40
Study 32343765 — intervention group
Group type: COMPARATOR
Intervention: Diversified diet (DD) control group, n=25, received conventional management.
Number of subjects: 40
Study 36241081 — intervention group
Group type: EXPERIMENTAL
Intervention: Catch-up Growth
Number of subjects: 235
Study 36241081 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistently Large
Number of subjects: 235
Study 32579776 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (25 mg)
Number of subjects: 57
Study 32579776 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (75 mg)
Number of subjects: 57
Study 32579776 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ-56136379 (150 mg)
Number of subjects: 57
Study 34244316 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma plus standard of care (CP+SOC)
Number of subjects: 160
Study 34244316 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 160
Study 34086631 — intervention group
Group type: EXPERIMENTAL
Intervention: 800-mg orally administered CBD
Number of subjects: 20
Study 34086631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 32648983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine mouthwash (4 mg/mL solution; dose 1 mg/kg)
Number of subjects: 44
Study 32648983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32648983 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine mouthwash
Number of subjects: 44
Study 32648983 — intervention group
Group type: COMPARATOR
Intervention: Ketamine mouthwash and Placebo
Number of subjects: 44
Study 34331080 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (up to 200 mg/day)
Number of subjects: 63
Study 34331080 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 33374970 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-iron formula (2 mg/L) fortified with bovine lactoferrin (1.0 g/L)
Number of subjects: 180
Study 33374970 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-iron formula unfortified with lactoferrin (2 mg/L)
Number of subjects: 180
Study 33374970 — intervention group
Group type: COMPARATOR
Intervention: Standard formula with 8 mg of iron/L and no lactoferrin fortification (Control)
Number of subjects: 180
Study 33374970 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-iron groups (combined)
Number of subjects: 180
Study 35633589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperchloremia (defined as 110 mmol/L or greater) with two or more occurrences within 48 hours
Number of subjects: 1275
Study 35633589 — intervention group
Group type: COMPARATOR
Intervention: Patients without hyperchloremia
Number of subjects: 1275
Study 33899452 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity laser therapy
Number of subjects: 0
Study 33899452 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional radiofrequency therapy
Number of subjects: 0
Study 33899452 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined methods (high-intensity laser therapy or micro-needling in combination with peels, fillers, PRP injection)
Number of subjects: 0
Study 33899452 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-needling as monotherapy
Number of subjects: 0
Study 33899452 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdermabrasion
Number of subjects: 0
Study 36384100 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 240
Study 36384100 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant interferon‐gamma
Number of subjects: 240
Study 36384100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 32151482 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Next (PTN)
Number of subjects: 27
Study 32151482 — intervention group
Group type: EXPERIMENTAL
Intervention: OneShape (OS)
Number of subjects: 27